Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 230 (RNA5SP230) is a genomic DNA sequence derived from the 5S ribosomal RNA gene family but rendered nonfunctional due to accumulated mutations or truncations. Pseudogenes such as RNA5SP230 are neither transcribed into functional RNA nor play a direct biological or therapeutic role. Pseudogenes arise commonly through gene duplication followed by loss of function, or by retrotransposition events. They are categorized separately from canonical genes or therapeutic targets, and do not code for proteins or functional RNAs[6][4]. Unlike authentic 5S rRNA, which is crucial for ribosome structure and function in protein synthesis[3][1], pseudogenes such as RNA5SP230 have no current known biological function and are not implicated in disease, drug interaction, or clinical biomarker roles. Key points: - This entry is not a therapeutic target. It is a nonfunctional pseudogene and is generally excluded from target databases that focus on active biological macromolecules (e.g., receptors, enzymes, transporters)[4][6]. - The name is technically correct within the conventions of pseudogene cataloging, but the entity itself should not be treated as a drug or therapeutic target. Thus, for most research and therapeutic use cases, designating this as a target would be incorrect. - Aliases provided are standardized synonyms from genetics nomenclature but all refer to the same nonfunctional genetic element. - No known molecular function, disease relevance, drug interaction, biomarker use, or safety concern is associated. - Molecular classification: This is best classified as an "Other – Pseudogene" and specifically, an "rRNA pseudogene"[4]. If you require data for an active ribosomal RNA or gene product, 5S ribosomal RNA (functional gene) would be a legitimate biological entity, but RNA5SP230 is a pseudogene and functionally inert[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 230 (RNA5SP230).